| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 09/05/2006 | US7102059 Isolated nucleic acid molecule containing one open reading frame; a nucleotide sequence, or a complementary sequence encoding proteins or polypeptides of Pseudomonas CEL and EEL genomic regions or hybridizes to a DNA molecule |
| 09/05/2006 | US7102057 Nucleotide sequences coding multiple enzymatic activities for use in grain, food and beverage processing and flavoring; fermentation of ethanol/alcoholic beverages |
| 09/05/2006 | US7101992 Nucleic acid base pair |
| 09/05/2006 | US7101990 Bax-responsive genes for drug target identification in yeast and fungi |
| 09/05/2006 | US7101984 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/05/2006 | US7101979 Antibodies to antiangiogenic compositions and methods |
| 09/05/2006 | US7101977 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
| 09/05/2006 | US7101974 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 09/05/2006 | US7101971 Erythropoietin analog-human serum albumin fusion |
| 09/05/2006 | US7101850 WISP polypeptides and nucleic acids encoding same |
| 09/05/2006 | US7101714 Nucleotide sequences coding polypeptide for us e in the diagnosis, prevention and treatment of inflammatory defects |
| 09/05/2006 | US7101702 Fermentative preparation process for and crystal forms of cytostatics |
| 09/05/2006 | US7101699 Comprises enzymatic polypeptide for treatment and prevention of neurodegenerative and cell proliferative disorders; wound healing agents |
| 09/05/2006 | US7101696 Polyhydroxyalkanoate synthase and gene encoding the same enzyme |
| 09/05/2006 | US7101695 Preparing protein cross-linking enzymes for use in food processing and drug delivevry |
| 09/05/2006 | US7101694 Comprises polypeptide which converts oxyluciferin to luciferin for use in medicine and food hygiene |
| 09/05/2006 | US7101693 Plasticized hydrophilic glasses for improved stabilization of biological agents |
| 09/05/2006 | US7101692 Identification of sortase gene |
| 09/05/2006 | US7101691 Alcohol production using sonication |
| 09/05/2006 | US7101690 Attenuated CCPA1 modified bacterial cell and its use for the preparation of L-amino acids |
| 09/05/2006 | US7101689 Interleukin-18 binding proteins, their preparation and use |
| 09/05/2006 | US7101684 Modified modular polyketide synthase |
| 09/05/2006 | US7101683 Hepatitis C virus (HCV) proteins; chemiluminescence; genetic engineering |
| 09/05/2006 | US7101559 Immunomodulatory protein and useful embodiments thereof |
| 09/05/2006 | US7101558 bvg-positive Bordetella bronchiseptica strain; grows at a higher rate, more reliably in a less expensive medium; purity |
| 09/05/2006 | US7101556 Preparation and usage of plasmodium fusion antigen |
| 09/05/2006 | US7101555 Microorganismal polypeptides for use in diagnosis and treatment of respiratory system disorders; genetic vaccines |
| 09/05/2006 | CA2377054C Biocontrol of weeds using pseudomonas compositions |
| 09/05/2006 | CA2234332C Method of obtaining a composition containing 9-cis-.beta.-carotene in high-purity |
| 09/03/2006 | WO2006096164A1 Media for clostridium bacterium and processes for obtaining a clostridial toxin |
| 09/03/2006 | WO2006096163A1 Animal product free system and process for purifying a botulinum toxin |
| 09/03/2006 | CA2556796A1 Animal product free system and process for purifying a botulinum toxin |
| 09/03/2006 | CA2556537A1 Media for clostridium bacterium and processes for obtaining a clostridial toxin |
| 08/31/2006 | WO2006091924A2 Producing carotenoids |
| 08/31/2006 | WO2006091733A2 Method for enhancing the immune response to staphylococcus aureus infection |
| 08/31/2006 | WO2006091677A1 Yeast strains expressing ribosome-inactivating protein domain and method of using same |
| 08/31/2006 | WO2006091470A2 Improved halohydrin dehalogenases and related polynucleotides |
| 08/31/2006 | WO2006091118A2 A NEW STRAIN OF PAENIBACILLUS CURDLANOLYTICUS, A METHOD OF MUTANASE PRODUCTION, THE APPLICATION OF α-L ,3-GLUCAN FOR THE PRODUCTION OF MUTANASE, AND AN ENZYMATIC PREPARATION |
| 08/31/2006 | WO2006090913A1 Method for degrading aromatic polyester using microorganism |
| 08/31/2006 | WO2006090780A1 Estrogenic substance degradable microorganism and use thereof |
| 08/31/2006 | WO2006090750A1 ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME |
| 08/31/2006 | WO2006090078A1 Method of modifying the viability of a lyophilized microorganism by treating the growth medium thereof with gases |
| 08/31/2006 | WO2006066594A3 Alpha-amylase variants |
| 08/31/2006 | WO2005018842A8 Abiogenic transition unit |
| 08/31/2006 | US20060195940 Transgenic plants having a modified carbohydrate content |
| 08/31/2006 | US20060195939 Delta-8 desaturase and its use in making polyunsaturated fatty acids |
| 08/31/2006 | US20060195936 Methods and compositions for tobacco plants with reduced nicotine |
| 08/31/2006 | US20060194951 Polynucleotides encoding interferon gamma polypeptides |
| 08/31/2006 | US20060194950 separating antibodies from proteases; provide a mutated immunoglobulin-binding protein ligand that exhibits an improved stability at increased pH-values, and accordingly an improved tolerance to cleaning under alkaline conditions |
| 08/31/2006 | US20060194735 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 08/31/2006 | US20060194731 Using tumor antigens to elicit immune response targeted to cancer cells; immunotherapy |
| 08/31/2006 | US20060194322 Culture media compositions free of Fetal Bovine Serum |
| 08/31/2006 | US20060194314 Novel Bt toxin receptors from lepidopteran insects and methods of use |
| 08/31/2006 | US20060194302 has resistance to to 150 mg/l primaquine ; for use as medicaments, chemical agents, food and/or feed additives; industrial scale; Escherichia coli H-9341 |
| 08/31/2006 | US20060194295 Novel, esterase, fungus capable of producing the same and method for producing the same |
| 08/31/2006 | US20060194293 Rb1 gene induced protein (rb1cc1) and gene |
| 08/31/2006 | US20060194291 Comprising human immunoglobulin g1 fc region, which mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity |
| 08/31/2006 | US20060194290 Polypeptide variants with altered effector function |
| 08/31/2006 | US20060194286 Apo-2LI and Apo-3 polypeptides |
| 08/31/2006 | US20060194285 Biological production of clavulanic acid and related compounds |
| 08/31/2006 | US20060194283 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/31/2006 | US20060194282 Contains at least one mutation that reduces or eliminates the ability of the fluorescent protein to oligomerize; determining the pH of a sample, presence of an enzyme, and activity of an enzyme by variation of fluorescence; kits |
| 08/31/2006 | US20060194278 Process for producing glucose dehydrogenase |
| 08/31/2006 | US20060194277 Method for producing target proteins by deleting or amplifyingibpa and/or ibpb gene coding for inclusion body-associated proteins |
| 08/31/2006 | US20060194236 Genetically engineering preferential bacteria; obtain bacteria that is stable containing desirable output traits, transform with expression vector, monitor bacteria for intensified mutation activity |
| 08/31/2006 | US20060193948 Tablet containing active dry yeast for breadmaking |
| 08/31/2006 | US20060193897 Enzyme feed additive and animal feed including it |
| 08/31/2006 | US20060193874 Vaccines for proliferative ileitis and methods of making and using the same |
| 08/31/2006 | US20060193861 Tumor necrosis factor receptors 6 alpha & 6 beta |
| 08/31/2006 | US20060193852 immunotherapy, preferably against B-cell malignancies such as non-Hodgkin lymphoma; single-chain multifunctional polypeptides comprising at least two binding sites specific for the CD19 and CD3 antigen; domains are arranged in the order VLCD19-VHCD19-VHCD3-VLCD3; vector; cell |
| 08/31/2006 | US20060193851 Human anti-factor IX/IXa antibodies |
| 08/31/2006 | US20060193842 Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life |
| 08/31/2006 | CA2785161A1 Mutant aox 1 promoters |
| 08/31/2006 | CA2642985A1 Culture media for increasing biopesticide producing microorganisms' pesticidal activity, methods of producing same, biopesticide producing microorganisms so produced |
| 08/31/2006 | CA2598539A1 Lactic acid and bacillaceae fertilizer and method of producing same |
| 08/31/2006 | CA2590719A1 Method of growing bacteria to deliver bioactive compounds to the intestine of ruminants |
| 08/30/2006 | EP1696035A2 Improved bacillus host cell |
| 08/30/2006 | EP1696030A1 TIE ligand homologues |
| 08/30/2006 | EP1696029A1 TIE ligand homologues |
| 08/30/2006 | EP1696028A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/30/2006 | EP1696027A1 Hla-dr-binding antigen peptide derived from wt1 |
| 08/30/2006 | EP1696025A2 Screening methods for enzymes and enzyme kits |
| 08/30/2006 | EP1694864A2 Compositions and methods for the diagnosis and treatment of tumor |
| 08/30/2006 | EP1694854A2 Novel carotenoids ketolases |
| 08/30/2006 | EP1694850A2 Plasmid system for multigene expression |
| 08/30/2006 | EP1694846A1 A cell with improved secretion mediated by mrga protein or homologue |
| 08/30/2006 | EP1694824A1 Method for preparing xylitol with high yield using recycling microorganism |
| 08/30/2006 | EP1694813A2 Method and device for division of a biological sample by magnetic effect |
| 08/30/2006 | EP1694699A1 Yeast strains with improved fructose fermentation capacity |
| 08/30/2006 | EP1482811B1 Process for the preparation of foods comprising a probiotic delivery system |
| 08/30/2006 | EP1479773B1 Mite galectin |
| 08/30/2006 | EP1266015B1 Ecdysone receptor-based inducible gene expression system |
| 08/30/2006 | EP1266008B1 Acute neuronal induced calcium binding protein type 1 ligand |
| 08/30/2006 | EP1210430B1 Muc-1 derived peptides |
| 08/30/2006 | EP1180524B1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
| 08/30/2006 | EP1151088B1 Improved phytases |
| 08/30/2006 | EP1124979B1 Production of 3-hydroxypropionic acid in recombinant organisms |
| 08/30/2006 | EP1109913B1 Nucleotide sequences which code for the opca gene |
| 08/30/2006 | EP1015596B1 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 08/30/2006 | EP0972036B1 Prion propagation inhibition by dominant-negative prion protein mutants |